EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into pharmaceutical companies regarding clinical trial sites located in China.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Coverage from Reuters, QZ, Endpoints News, Stat News, and Pharmaphorum highlights that Merck, AbbVie, Bristol Myers, and Pfizer have been asked to defend their involvement in these operations. The investigation centers on the oversight and location of international clinical research facilities.
Future updates will depend on the responses provided by the pharmaceutical companies to the House committee. Official statements regarding the scope of the inquiry and potential legislative reactions remain pending.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (67% supported) Updated just now.
Quick answers
Which companies are being investigated?
According to reports, the probe involves Merck, AbbVie, Bristol Myers, and Pfizer.
What is the focus of the investigation?
The committee is examining drug trial sites in China and potential links to the Chinese military.
Who initiated the inquiry?
The investigation was opened by the US House Select Committee on the Chinese Communist Party.
Coverage (5)
- Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more statnews.com · 2h ago
- Drugmakers asked to defend Chinese trials; reports pharmaphorum · 2h ago
- Congress is investigating Merck and AbbVie over drug trials in China tied to its military qz.com · 2h ago
- Exclusive: House China panel questions Bristol Myers, Pfizer on trial sites Endpoints News · 2h ago
- EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials Reuters · 2h ago
Topics
Related trends
EU and China seek to head off trade war with new dialogue
The European Union and China have launched a consultation mechanism to address trade imbalances and avert a potential trade conflict.
Toyota sales fall for fourth month in May as declines in China, US and Middle East weigh
Toyota reports a global sales decline for the fourth consecutive month as regional performance shifts across key international markets.
China's Momenta kicks off Hong Kong IPO, targets up to $751 million
Chinese autonomous driving startup Momenta is launching a Hong Kong IPO, seeking up to $751 million to advance its research and development.
A long-awaited Australia-Vanuatu pact blocks China from building a military base
Australia and Vanuatu have signed the long-awaited Nakamal pact, a security agreement prohibiting the construction of foreign military bases in the nation.
EU confronts ‘China shock’ ahead of pivotal Brussels trade talks
The European Union and China have initiated a high-stakes series of trade negotiations, setting an October deadline to address a €360bn deficit.
China targets more Japanese companies with export controls
China has placed 40 Japanese entities under new export controls, escalating trade tensions with Tokyo.